These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3950917)

  • 1. Neurochemistry of aging. 1. Toxins for an animal model of Alzheimer's disease.
    Mistry JS; Abraham DJ; Hanin I
    J Med Chem; 1986 Mar; 29(3):376-80. PubMed ID: 3950917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
    Fisher A; Mantione CR; Abraham DJ; Hanin I
    J Pharmacol Exp Ther; 1982 Jul; 222(1):140-5. PubMed ID: 6896342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AF64a-treated mouse: possible model for central cholinergic hypofunction.
    Mantione CR; Fisher A; Hanin I
    Science; 1981 Jul; 213(4507):579-80. PubMed ID: 6894649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW; Watson M; Leventer SM; Roeske WR; Hanin I; Yamamura HI
    J Pharmacol Exp Ther; 1985 Dec; 235(3):577-82. PubMed ID: 3841155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
    Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
    Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible and irreversible inhibition of high-affinity choline transport caused by ethylcholine aziridinium ion.
    Pittel Z; Fisher A; Heldman E
    J Neurochem; 1987 Aug; 49(2):468-74. PubMed ID: 3598581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral injections of AF64A: an animal model of Alzheimer's disease?
    Jarrard LE; Levy A; Meyerhoff JL; Kant GJ
    Ann N Y Acad Sci; 1985; 444():520-2. PubMed ID: 3860115
    [No Abstract]   [Full Text] [Related]  

  • 8. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylcholine mustard aziridinium ion and its choline analogue on choline transport into synaptosomes.
    Rylett BJ; Colhoun EH
    Can J Physiol Pharmacol; 1977 Aug; 55(4):769-72. PubMed ID: 902152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cytotoxicity of ethylcholine mustard aziridinium in cerebral microvascular endothelial cells.
    Gómez C; Martín C; Galea E; Estrada C
    J Neurochem; 1993 Apr; 60(4):1534-9. PubMed ID: 8455040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
    Fisher A; Hanin I
    Annu Rev Pharmacol Toxicol; 1986; 26():161-81. PubMed ID: 3087271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanisms involved in the presynaptic cholinotoxicity due to ethylcholine aziridinium (AF64A) in vivo.
    Mantione CR; Fisher A; Hanin I
    Life Sci; 1984 Jul; 35(1):33-41. PubMed ID: 6330483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and neurochemical effects of the presumed cholinergic toxin AF64A in the rat interpeduncular nucleus.
    Villani L; Contestabile A; Migani P; Poli A; Fonnum F
    Brain Res; 1986 Aug; 379(2):223-31. PubMed ID: 3742221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) transiently affects somatostatin and neuropeptide Y levels in rat brain.
    Hörtnagl H; Sperk G; Sobal G; Maas D
    J Neurochem; 1990 May; 54(5):1608-13. PubMed ID: 1969935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemistry of aging. 2. Design, synthesis, and biological evaluation of halomethyl analogues of choline with high affinity choline transport inhibitory activity.
    Mistry JS; Abraham DJ; Kozikowski AP; Hanin I
    J Med Chem; 1991 Jul; 34(7):2031-6. PubMed ID: 2066974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
    Potter PE; Tedford CE; Kindel G; Hanin I
    Brain Res; 1989 May; 487(2):238-44. PubMed ID: 2525061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethylcholine aziridinium ion depletes acetylcholine and causes muscarinic receptor supersensitivity in rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    Neurosci Lett; 1990 Feb; 109(3):304-8. PubMed ID: 2330132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotoxicity of ethylcholine mustard aziridinium (ECMA) in rat brain reaggregate cultures.
    Pillar AM; Prince AK; Atterwill CK
    Toxicology; 1988 Apr; 49(1):115-9. PubMed ID: 2836967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical and behavioral effects of N-ethyl-acetylcholine aziridinium chloride in mice.
    Pope CN; Ho BT; Wright AA
    Pharmacol Biochem Behav; 1987 Feb; 26(2):365-71. PubMed ID: 3575357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.